Envision Healthcare Holdings, Inc. Files Registration Statement for Secondary Offering of Common Stock

Envision Healthcare Holdings, Inc. (NYSE: EVHC) (“Envision” or the “Company”) today announced that it has filed a registration statement with the U.S. Securities and Exchange Commission relating to a proposed secondary offering of 27,500,000 shares of its common stock by certain stockholders of the Company. Investment funds sponsored by, or affiliated with, Clayton, Dubilier & Rice, LLC and certain executive officers, directors and employees of the Company will be the selling stockholders. In connection with the offering, the selling stockholders will grant the underwriters an option to purchase up to 4,125,000 additional shares of common stock. The Company will not receive any proceeds from the proposed secondary offering. The proposed secondary offering will be made only by means of a prospectus.

Goldman, Sachs & Co., Barclays, BofA Merrill Lynch and Citigroup are serving as lead joint book-running managers and as representatives of the underwriters for the proposed secondary offering.

When available, copies of the preliminary prospectus relating to the proposed secondary offering may be obtained from Goldman, Sachs & Co., Attention: Prospectus Department, 200 West Street, New York, New York 10282, or by telephone at 1-866-471-2526, or by facsimile at 1-212-902-9316 or by email at prospectus-ny@ny.email.gs.com; Barclays, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, telephone: (888) 603-5847, or by e-mail: barclaysprospectus@broadridge.com; BofA Merrill Lynch, 222 Broadway, New York, NY 10038, Attn: Prospectus Department or by email at dg.prospectus_requests@baml.com; or Citigroup, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, telephone: (800) 831-9146, or by e-mail: prospectus@citi.com.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these shares in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any state.

About Envision Healthcare

Envision Healthcare and our more than 30,000 employees and affiliated clinicians, offer an array of healthcare related services to consumers, hospitals, healthcare systems, health plans and local, state and national government entities. Envision Healthcare operates American Medical Response, Inc. (“AMR”), EmCare Holdings, Inc. (“EmCare”) and Evolution Health, LLC (“Evolution Health”). AMR is a provider and manager of community-based medical transportation services, including emergency (‘911”), non-emergency, managed transportation, fixed-wing air ambulance and disaster response. EmCare is a provider of integrated facility-based physician services, including emergency, anesthesiology, hospitalist/inpatient care, radiology, teleradiology and surgery. Evolution Health provides comprehensive care to patients across various settings, many of whom suffer from advanced illnesses and chronic diseases. The Company is headquartered in Greenwood Village, Colorado.

Forward-Looking Statements

Certain statements and information herein may be deemed to be “forward-looking statements” within the meaning of the Federal Private Securities Litigation Reform Act of 1995. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements (other than statements of historical facts) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future, including statements with respect to the proposed secondary offering. Any forward-looking statements herein are made as of the date of this press release, and the Company undertakes no duty to update or revise any such statements. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in the Company’s periodic filings with the Securities and Exchange Commission from time to time, including in the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K.